SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as investors react to a significant expansion of its partnership with Nvidia, which integrates the QNX operating system into safety-critical edge AI platforms for robotics and industrial applications. The community is actively discussing this as a potential fundamental inflection point, moving beyond the stock's previous meme-status reputation toward a narrative focused on its essential role in the emerging physical AI and software-defined vehicle sectors.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is experiencing high volatility as investors weigh strong quarterly earnings and aggressive share buybacks against cautious forward guidance and the departure of a long-standing board member. The community remains deeply divided, with many retail traders actively buying the dip, while others express concerns over institutional selling pressure and potential downside risks.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is currently trending amid a significant strategic shift as the company acquires Brazil's Serra Verde Group in a transaction aimed at securing a non-Asian source for key magnetic rare earth elements. While investors and market analysts are actively debating the potential for long-term supply chain dominance and government-backed infrastructure status, the stock is seeing heightened volatility due to concerns over share dilution and the aggressive positioning of short sellers.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is facing intense downward pressure and hitting record lows as investors react to continued share dilution and skepticism surrounding the companys path to profitability. The community remains deeply divided, with some traders betting on a potential short squeeze or buyout, while many others are expressing frustration over management's performance and the stock's persistent freefall.

Newcourt Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2021 and is headquartered in Oakland, CA.

Psyence Biomedical Ltd.

Psyence Biomedical is experiencing high volatility and retail interest driven by an executive order to fast-track psychedelic research, which market participants view as a significant catalyst for ibogaine-based treatments. The community is actively debating the stock's potential for a massive short squeeze given its exceptionally low float, while cautious traders warn of the risks associated with micro-cap volatility and the potential for aggressive dilution.

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group (CAR) is surging due to a massive, persistent short squeeze that has left a high percentage of the float shorted and unable to cover, fueling intense community discussion about market manipulation versus genuine momentum. Traders are polarized between retail bulls riding the parabolic climb toward all-time highs and skeptical short-sellers bracing for an eventual, violent mean reversion.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi LLC is facing significant volatility and intense community scrutiny following a sudden leadership shakeup where both the CEO and CFO departed, fueling concerns over transparency and governance. Investors are actively debating whether this transition, paired with the ongoing search for a major anchor tenant for the Matador data center project, represents a structural breakdown or a strategic pivot toward professionalizing the company for future growth.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Atai Beckley, Inc. is a clinical-stage biopharmaceutical company focused on developing effective, rapid-acting, and convenient mental health treatments. The company is headquartered in New York, NY.

AtaiBeckley Inc.

ATAI is trending as the market reacts to an executive order aimed at fast-tracking psychedelic drug research for veterans and mental health, fueling speculation about clinical acceleration and potential pharmaceutical partnerships for the company's BPL-003 candidate. Community sentiment is divided between optimism regarding recent pipeline milestones and clinical validation versus frustration over historical share dilution and persistent intraday price weakness.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Niagen Bioscience Collaborates with USP to Establish First-Ever USP Monograph for Nicotinamide Riboside Chloride (NRCl), the Patented Form in Niagen

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces that Nicotinamide Riboside Chloride (NRCl), the patented form of nicotinamide riboside in the Companys flagship ingredient, Niagen...

JPMorgan Chase & Co. Makes New $3.68 Million Investment in Niagen Bioscience, Inc. $NAGE

JPMorgan Chase & Co. bought a new position in shares of Niagen Bioscience, Inc. (NASDAQ:NAGE - Free Report) during the third quarter, according to the company in its most recent filing with the...

Niagen Bioscience's (NAGE) Buy Rating Reiterated at Canaccord Genuity Group

Canaccord Genuity Group restated a "buy" rating and issued a $13.00 price target on shares of Niagen Bioscience in a research note on Tuesday...

Niagen Bioscience Announces First Cruise Ship Clinic Partnership with OneSpaWorld, Bringing the NAD-Boosting Benefits of Niagen IV to the High Seas

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced OneSpaWorld (NASDAQ: OSW) as the...

Niagen Bioscience, Inc. (NASDAQ:NAGE) Short Interest Down 13.6% in March

Niagen Bioscience, Inc. (NASDAQ:NAGE - Get Free Report) was the target of a large decrease in short interest in the month of March. As of March 13th, there was short interest totaling 5,578,868...

Niagen Bioscience (NASDAQ:NAGE) Upgraded at Wall Street Zen

Wall Street Zen raised Niagen Bioscience from a "hold" rating to a "buy" rating in a research report on Saturday...

Niagen Bioscience Increases Share Repurchase Program to $20 Million

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that its Board of Directors has...

Niagen Bioscience Surpasses 300 External Research Agreements from Leading Global Institutions on Niagen, Contributing to 45 Published Clinical Studies

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that its external research...

Niagen Bioscience Launches Niagen Skincare Innovation Lab and Debuts Dermatologist-Tested Niagen NanoCloud, From Tru Niagen Powered by Patented Niagen

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the launch of Niagen Skincare...

HC Wainwright Issues Optimistic Outlook for NAGE Earnings

Niagen Bioscience, Inc. (NASDAQ:NAGE - Free Report) - HC Wainwright increased their Q1 2026 earnings estimates for shares of Niagen Bioscience in a report released on Thursday, March 5th. HC...

Niagen Bioscience, Inc. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. It is pioneering research on nicotinamide adenine dinucleotide (NAD+). The company’s patent portfolio includes Nicotinamide Riboside (NR) and other NAD+ precursors, which are commercialized as the flagship ingredient Niagen. It operates through the following segments: Consumer Products, Ingredients, Analytical Reference Standards and Services, and Pharmaceuticals. The Consumer Products segment provides finished dietary supplement products that contain the firm’s proprietary ingredients directly to consumers as well as to distributors. The Ingredients segment supplies ingredients as raw materials to the manufacturers of consumer products. The Analytical Reference Standards and Services segment includes supply of phytochemical reference standards and other research and development services. The Pharmaceuticals segment focuses on the pharmaceutical development of NAD precursor portfolio for potential therapeutic applications in rare diseases. The company was founded by Mark S. Germain and Frank L. Jaksch, Jr. in 1999 and is headquartered in Los Angeles, CA.

NAGE
Niagen Bioscience Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest NAGE News

NAGENiagen Bioscience Inc